Hypermagnesemia and hyperphosphatemia are highly prevalent in patients with COVID-19 and increase the risk of death
International Journal Of Infectious DiseasesPeer ReviewedJustyna Malinowska +42022Journals
Nonrespiratory manifestations of COVID-19 include endocrine disorders, among which are calcium-magnesium-phosphate homeostasis abnormalities, which seem to influence the disease severity and patient outcome. The aim of this study was to evaluate the prevalence and impact of calcium-magnesium-phosphate and vitamin D3 disorders on survival in patients hospitalized for COVID-19 depending on the severity of the disease and kidney function.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support